Clinical Trial Update: Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Synflutide HFA Inhaler with Seretide Evohaler in healthy volunteers without a charcoal block; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seretide Evohaler (salmeterol/fluticasone)
• Synflutide HFA Inhaler

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED